Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aspartate decarboxylase (PanD) is an essential bacterial enzyme involved in vitamin B5 biosynthesis via conversion of L-aspartic acid into β-alanine, making it both vital for cellular metabolism and an attractive drug target, most notably implicated in mechanisms underlying antibiotic resistance.
Inhibition of aspartate decarboxylase activity, leading to disruption of pantothenate synthesis and CoA production
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aspartate decarboxylase (None).